These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9875976)

  • 1. Treatment of tufted angioma with interferon alfa: role of bFGF.
    Robenzadeh A; Don PC; Weinberg JM
    Pediatr Dermatol; 1998; 15(6):482. PubMed ID: 9875976
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon for tufted angioma.
    Wollina U
    Pediatr Dermatol; 1999; 16(4):338. PubMed ID: 10515775
    [No Abstract]   [Full Text] [Related]  

  • 3. Response of deep tufted angioma to interferon alfa.
    Suarez SM; Pensler JM; Paller AS
    J Am Acad Dermatol; 1995 Jul; 33(1):124-6. PubMed ID: 7601929
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases.
    Marler JJ; Rubin JB; Trede NS; Connors S; Grier H; Upton J; Mulliken JB; Folkman J
    Pediatrics; 2002 Feb; 109(2):E37. PubMed ID: 11826247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of bFGF ("basic fibroblast growth factor") for diagnosis and treatment of hemangiomas].
    Dosquet C; Coudert MC; Wassef M; Enjolras O; Drouet L
    Ann Dermatol Venereol; 1998 May; 125(5):313-6. PubMed ID: 9747277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant interferon alfa-2b for high-risk melanoma.
    Retsas S
    J Clin Oncol; 1996 Jun; 14(6):1968-9. PubMed ID: 8656272
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a.
    Kaban LB; Mulliken JB; Ezekowitz RA; Ebb D; Smith PS; Folkman J
    Pediatrics; 1999 Jun; 103(6 Pt 1):1145-9. PubMed ID: 10353921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2b.
    Vermeulen PB; Dirix LY; Martin M; Lemmens J; Van Oosterom AT
    J Natl Cancer Inst; 1997 Sep; 89(17):1316-7. PubMed ID: 9293925
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma.
    Lohmann CP; Kroher G; Bogenrieder T; Spiegel D; Preuner J
    Lancet; 1999 Apr; 353(9161):1326. PubMed ID: 10218534
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon adjuvant therapy of melanoma.
    Kirkwood JM; Wazer D; Rosenstein M
    Cancer; 1997 May; 79(9):1843-6. PubMed ID: 9129006
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant interferon in the treatment of melanoma.
    Middleton MR
    Br J Cancer; 1999 Aug; 80(11):1679-80. PubMed ID: 10468281
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of angioblastoma with recombinant interferon-alpha 2.
    Park KC; Ahn PS; Lee YS; Kim KH; Cho KH
    Pediatr Dermatol; 1995 Jun; 12(2):184-6. PubMed ID: 7659649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorting the hype from the facts in melanoma.
    Autier P; Boyle P; Doré JF
    Lancet; 1998 Aug; 352(9129):738-9. PubMed ID: 9729018
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical prognostic factors in adjuvant melanoma trial.
    Nathanson L
    J Clin Oncol; 1996 Jun; 14(6):1967-8. PubMed ID: 8656271
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of local PUVA-therapy and interferon alpha-2A in the treatment of tumoral stage mycosis fungoides.
    Delpuget-Bertin N; Bernard P; Bedane C; Dang PM; Bonnetblanc JM
    Dermatology; 1996; 193(1):74-5. PubMed ID: 8864634
    [No Abstract]   [Full Text] [Related]  

  • 16. Levels of angiogenic peptides in sera from patients with carcinoid tumours during alpha-interferon treatment.
    Nilsson A; Janson ET; Eriksson B; Larsson A
    Anticancer Res; 2001; 21(6A):4087-90. PubMed ID: 11911297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal management of diffuse neonatal hemangiomatosis.
    Blei F; Orlow SJ; Geronemus R
    J Am Acad Dermatol; 1997 Dec; 37(6):1019-21. PubMed ID: 9418785
    [No Abstract]   [Full Text] [Related]  

  • 18. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
    Spaccarelli N; Rook AH
    Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant IFN alpha2 therapy of melanoma.
    Kirkwood JM
    Lancet; 1998 Jun; 351(9120):1901-3. PubMed ID: 9654253
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective control of rush progression of CD8+ mycosis fungoides with pegylated interferon.
    Fujimura T; Okuyama R; Hashimoto A; Watanabe H; Nakagawa S; Tagami H; Aiba S
    Acta Derm Venereol; 2006; 86(2):161-2. PubMed ID: 16648924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.